3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Pituitary Neoplasms
7
Prolactinoma
5
Polycystic Ovary Syndrome
3
Pituitary ACTH Hypersecretion
3
Hyperprolactinemia
2
Acromegaly
2
Recurrence
1
Prostatic Neoplasms
1
Prolactin Deficiency, Isolated
1
Ovarian Hyperstimulation Syndrome
1
Neuroendocrine Tumors
1
Neoplasms
1
Melanoma
1
Dumping Syndrome
1
Breast Neoplasms
1
Brain Neoplasms
1
Adrenocortical Hyperfunction
1
Adenoma
1
ACTH-Secreting Pituitary Adenoma
1
Interventions
Cabergoline
2
ropinirole
1
Gonadotropin-Releasing Hormone
1
Dopamine Agonists
1
Clomiphene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Hyperprolactinemia
×
Cabergoline
×
Clear all
NCT07463235
2026-03-13
SPARAGMOS
University of Sao Paulo General Hospital
Phase 3
Recruiting
70 enrolled
NCT07045935
2025-09-23
ProBOLIC
University Hospital, Basel, Switzerland
Phase 4
Recruiting
60 enrolled